When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

When Cancer Looks Like Something Else:  How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?
Historically difficult to diagnose, Dr. Elizabeth Griffiths reveals how to properly recognize, identify and diagnose Myelodysplasia.

Available credits: 0.25

Time to complete: 30 min


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    In this segment, Dr. Griffiths discusses what MDS is and the importance of that, as well as the mutational profiling in normal aging and MDS and distinguishing mutations from the disease.

    This activity is part of a series of in-depth discussions with oncology thought leaders from the Roswell Park Comprehensive Cancer Center Institute in Buffalo, New York targeting primary care and family physicians.

    This series was made possible through the generous support of BlueCross BlueShield of Western New York.


  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. 

    Elizabeth Griffiths, MD, 
    Associate Professor of Oncology
    Director of MDS
    Roswell Park Comprehensive Cancer Center
    Buffalo, NY   


    • Sean T. Barrett has nothing to disclose.
    • Laurel DiBrog has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Janet J. Harszlak, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Ashley Snowden has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss what MDS is and why I should care
    • Describe mutational profiling in normal aging and MDS
    • Distinguish mutations from disease
  • Target Audience

    This activity is designed to meet the educational needs of Primary Care Physicians and Oncologists.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and Roswell Park Comprehensive Cancer Center of Buffalo, New York. TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from BlueCross BlueShield of Western New York.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of TOPEC, you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments



Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now